Melasma-like hyperpigmentation: A rare side effect of imatinib mesylate
Imatinib mesylate is an oral tyrosine kinase inhibitor used chiefly to treat chronic myeloid leukemia. In the literature, hypopigmentation is a commonly reported side effect of imatinib therapy; however, the cases of melasma-like hyperpigmentation due to imatinib have also been sparingly reported. W...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Serier: | Journal of the Scientific Society |
| Fag: | |
| Online adgang: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2023;volume=50;issue=2;spage=275;epage=277;aulast=Agrawal |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|